Korean J Dermatol.
2019 Jun;57(5):292-293.
Depigmentation in a Patient with Chronic Myeloid Leukemia during Chemotherapy with Dasatinib
- Affiliations
-
- 1Department of Dermatology, School of Medicine, Catholic University of Daegu, Daegu, Korea. magincia@cu.ac.kr
Abstract
- No abstract available.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Dasatinib (Sprycel®)-Associated Acneiform Eruption Improved by Dose Reduction due to Pleural Effusion in a Patient with Chronic Myeloid Leukemia
- A Case of Chronic Myeloid Leukemia with Multiple Chloromas Treated Successfully with Dasatinib
- Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib
- Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia
- Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review
